Improving drug biological effects by encapsulation into polymeric nanocapsules

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 5, 2015, Pages 623-639

  Frank, Luiza A ^a   Contri, Renata V ^a   Beck, Ruy C R ^a   Pohlmann, Adriana R ^a   Guterres, Silvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; POLYMERS; TARGETED DRUG DELIVERY;

ADVERSE EFFECT; BIOLOGICAL EFFECTS; LIPID-CORE NANOCAPSULES; PHOTO-STABILITY; POLYMERIC NANOCAPSULES; POLYMERIC NANOPARTICLES; STATE OF THE ART; THERAPEUTIC CLASS;

NANOCAPSULES;

NANOCAPSULE; POLYMER; DRUG; DRUG CARRIER;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL COMPOSITION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG STABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NANOENCAPSULATION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; ANIMAL; CHEMISTRY;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOCAPSULES; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 84937794070     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1334     Document Type: Article

References (79)

1. Thomson Reuters, Web of Science™. Available at: http://www.webofscience.br. (Accessed July 29, 2014).
2. Legrand P, Barratt G, Mosqueira V, Fessi H, Devissaguet JP. Polymeric nanocapsules as drug delivery systems. A review. STP Pharma Sci 1999, 9:411-418.
3. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst 2002, 19:99-134.
4. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009, 26:1025-1058.
5. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010, 385:113-142. doi:10.1016/j.ijpharm.2009.10.018.
6. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ε{lunate}-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004, 278:1-23.
7. Pohlmann AR, Fonseca FN, Paese K, Detoni CB, Coradini K, Beck RC, Guterres SS. Poly (ε{lunate}-caprolactone) microcapsules and nanocapsules in drug delivery. Expert Opin Drug Deliv 2013, 10:623-638. doi:10.1517/17425247.2013.769956.
8. Chen CK, Law WC, Aalinkeel R, Yu Y, Nair B, Wu J, Mahajan S, Reynolds JL, Li Y, Lai CK, et al. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale 2014, 6:1567-1572. doi:10.1039/c3nr04804g.
9. Rata-Aguilar A, Sánchez-Moreno P, Jódar-Reyes AB, Martín-Rodríguez A, Boulaiz H, Marchal-Corrales JA, Peula-García JM, Ortega-Vinuesa JL. Colloidal stability and "in vitro" antitumor targeting ability of lipid nanocapsules coated by folate-chitosan conjugates. J Bioact Compat Polym 2012, 27:388-404. doi:10.1177/0883911512447492.
10. Grebinişan D, Holban M, Şunel V, Popa M, Desbrieres J, Lionte C. Novel acyl derivatives of N-(p-aminobenzoyl)-L-glutamine encapsulated in polymeric nanocapsules with potential antitumoral activity. Cell Chem Technol 2011, 45:571-577.
11. Contri RV, Frank LA, Kaiser M, Pohlmann AR, Guterres SS. The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids. Int J Nanomedicine 2014, 9:951-962. doi:10.2147/IJN.S56579.
12. Contri RV, Katzer T, Ourique AF, da Silva ALM, Beck RC, Pohlmann AR, Guterres SS. Combined effect of polymeric nanocapsules and chitosan hydrogel on the increase of capsaicinoids adhesion to the skin surface. J Biomed Nanotechnol 2014, 10:820-830. doi:10.1166/jbn.2013.1752.
13. Frank LA, Sandri G, D'Autilia F, Contri RV, Bonferoni MC, Caramella C, Frank AG, Pohlmann AR, Guterres SS. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery. Int J Nanomedicine 2014, 9:3151-3161. doi:10.2147/IJN.S62599.
14. Bernardi A, Zilberstein ACCV, Jäger E, Campos MM, Morrone FB, Calixto JB, Pohlmann AR, Guterres SS, Battastini AMO. Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol 2009, 158:1104-1111.
15. Fichter M, Baier G, Dedters M, Pretsch L, Pietrzak-Nguyen A, Landfester K, Gehring S. Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages. Nanomed Nanotechnol Biol Med 2013, 9:1223-1234. doi:10.1016/j.nano.2013.05.005.
16. Baier G, Baumann D, Siebert JM, Musyanovych A, Mailänder V, Landfester K. Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules. Biomacromolecules 2012, 13:2704-2715. doi:10.1021/bm300653v.
17. Zhao M, Biswas A, Hu B, Joo KI, Wang P, Gu Z, Tang Y. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 2011, 32:5223-5230. doi:10.1016/j.biomaterials.2011.03.060.
18. Bulcão RP, de Freitas FA, Dallegrave E, Venturini CG, Baierle M, Durgante J, Sauer E, Cassini C, Cerski CT, Zielinsky P, et al. In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration. Eur J Pharm Biopharm 2014, 86:167-177. doi:10.1016/j.ejpb.2013.04.001.
19. Dimer FA, Ortiz M, Pase CS, Roversi K, Friedrich RB, Pohlmann AR, Burger ME, Guterres SS. Nanoencapsulation of olanzapine increases its efficacy in antipsychotic treatment and reduces adverse effects. J Biomed Nanotechnol 2014, 10:1137-1145. doi:10.1166/jbn.2014.1817.
20. Friedrich RB, Dimer FA, Guterres SS, Beck RCR, Pohlmann AR. Nanoencapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrations. J Biomed Nanotechnol 2014, 10:1599-1609. doi:10.1166/jbn.2014.1842.
21. Pissinate K, dos Santos Martins-Duarte É, Schaffazick SR, de Oliveira CP, Vommaro RC, Guterres SS, Pohlmann AR, de Souza W. Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis. Parasitol Res 2014, 113:555-564. doi:10.1007/s00436-013-3715-6.
22. Yurgel VC, Oliveira CP, Begnini KR, Schultze E, Thurow HS, Leon PM, Dellagostin OA, Campos VF, Beck RCR, Guterres SS, et al. Methotrexate diethyl ester-loaded lipid-core nanocapsules in aqueous solution increased antineoplastic effects in resistant breast cancer cell line. Int J Nanomedicine 2014, 9:1583-1591. doi:10.2147/IJNS.S56506.
23. Silva ALD, M, Contri RV, Jornada DS, Pohlmann AR, Guterres SS. Vitamin K1-loaded lipid-core nanocapsules: physicochemical characterization and in vitro skin permeation. Skin Res Technol 2013, 19:e223-e230. doi:10.1111/j.1600-0846.2012.00631.x.
24. Frozza RL, Bernardi A, Hoppe JB, Meneghetti AB, Battastini AMO, Pohlmann AR, Guterres SS, Salbego C. Lipid-core nanocapsules improve the effects of resveratrol against Aβ-induced neuroinflammation. J Biomed Nanotechnol 2013, 9:2086-2104. doi:10.1166/jbn.2013.1709.
25. Bernardi A, Frozza RL, Meneghetti A, Hoppe JB, Battastini AMO, Pohlmann AR, Guterres SS, Salbego CG. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models. Int J Nanomedicine 2012, 7:4927-4942. doi:10.2147/IJN.S35333.
26. Bulcão RP, de Freitas FA, Venturini CG, Dallegrave E, Durgante J, Göethel G, Cerski CTS, Zielinsky P, Pohlmann AR, Guterres SS, et al. Acute and subchronic toxicity evaluation of poly (epsilon-caprolactone) lipid-core nanocapsules in rats. Toxicol Sci 2012, 132:162-176. doi:10.1093/toxsci/kfs334.
27. Detoni CB, Souto GD, da Silva ALM, Pohlmann AR, Guterres SS. Photostability and skin penetration of different E-resveratrol-loaded supramolecular structures. Photochem Photobiol 2012, 88:913-921. doi:10.1111/j.1751-1097.2012.01147.x.
28. Külkamp IC, Rabelo BD, Berlitz SJ, Isoppo M, Bianchin MD, Schaffazick SR, Pohlmann AR, Guterres SS. Nanoencapsulation improves the in vitro antioxidant activity of lipoic acid. J Biomed Nanotechnol 2011, 7:598-607. doi:10.1166/jbn.2011.1318.
29. Marchiori MCL, Ourique AF, Silva CDB, Raffin RP, Pohlmann AR, Guterres SS, Beck RCR. Spray-dried powders containing tretinoin-loaded engineered lipid-core nanocapsules: development and photostability study. J Nanosci Nanotechnol 2012, 12:2059-2067. doi:10.1166/jnn.2011.5192.
30. Ourique AF, Melero A, Silva CDBD, Schaefer UF, Pohlmann AR, Guterres SS, Lehr CM, Kostka KH, Beck RCR. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011, 79:95-101. doi:10.1016/j.ejpb.2011.03.008.
31. Cattani VB, Fiel LA, Jäger A, Jäger E, Colomé LM, Uchoa F, Stefani V, Dalla Costa T, Guterres SS, Pohlmann AR. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur J Pharm Sci 2010, 39:116-124. doi:10.1016/j.ejps.2009.11.004.
32. Ianiski FR, Alves CB, Souza ACG, Pinton S, Roman SS, Rhoden CR, Alves MP, Luchese C. Protective effect of meloxicam-loaded nanocapsules against amyloid-β peptide-induced damage in mice. Behav Brain Res 2012, 230:100-107. doi:10.1016/j.bbr.2012.01.055.
33. Ourique AF, Azoubel S, Ferreira CV, Silva CB, Marchiori MCL, Pohlmann AR, Guterres SS, Beck RC. Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: development and in vitro antitumor activity on human myeloid leukaemia cells. J Biomed Nanotechnol 2010, 6:214-223. doi:10.1166/jbn.2010.1120.
34. Bernardi A, Braganhol E, Jäger E, Figueiró F, Edelweiss MI, Pohlmann AR, Guterres SS, Battastini AM. Indomethacin-loaded nanocapsules treatment reduces in vitro glioblastoma growth in a rat glioma model. Cancer Lett 2009, 281:53-63. doi:10.1016/j.canlet.2009.02.018.
35. Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RCR. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. J Biomed Nanotechnol 2009, 5:254-263. doi:10.1166/jbn.2009.1030.
36. Külkamp IC, Paese K, Guterres SS, Pohlmann AR. Estabilização do ácido lipoico via encapsulação em nanocápsulas poliméricas planejadas para aplicação cutânea. Quím Nova 2009, 32:2078-2084.
37. Bernardi A, Frozza RL, Jäger E, Figueiró F, Bavaresco L, Salbego C, Pohlmann AR, Guterres SS, Battastini AM. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. Eur J Pharmacol 2008, 586:24-34. doi:10.1016/j.ejphar.2008.02.026.
38. Rigo LA, Frescura V, Fiel L, Coradini K, Ourique AF, Emanuelli T, Quatrin A, Tedesco S, Da Silva CB, Guterres SS, et al. Influence of the type of vegetable oil on the drug release profile from lipid-core nanocapsules and in vitro genotoxicity study. Pharm Dev Technol 2014, 19:789-798. doi:10.3109/10837450.2013.829097.
39. Silveira EFD, Chassot JM, Teixeira FC, Azambuja JH, Debom G, Beira FT, Del Pino FAB, Lourenço A, Horn AP, Cruz L, et al. Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme. Invest New Drugs 2013, 31:1424-1435. doi:10.1007/s10637-013-0016-y.
40. Fachinetto JM, Ourique AF, Lubini G, Tedesco SB, Silva AC, Ruy CR. Tretinoin-loaded polymeric nanocapsules: evaluation of the potential to improve the antiproliferative activities on Allium cepa root-tip compared to the free drug. Lat Am J Pharm 2008, 27:668-673.
41. Benvegnú DM, Barcelos RCS, Boufleur N, Pase CS, Reckziegel P, Flores FC, Ourique AF, Dalla Nora M, Da Silva CB, Beck RCR, et al. Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats. Neurochem Int 2012, 61:623-631. doi:10.1016/j.neuint.2012.06.015.
42. Benvegnú DM, Barcelos R, Boufleur N, Reckziegel P, Pase CS, Ourique AF, Beck RCR, Bürger ME. Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats. Eur J Pharm Biopharm 2011, 77:332-336. doi:10.1016/j.ejpb.2010.12.016.
43. Almeida JS, Lima F, Da Ros S, Bulhoes LO, de Carvalho LM, Beck RC. Nanostructured systems containing rutin: in vitro antioxidant activity and photostability studies. Nanoscale Res Lett 2010, 5:1603-1610. doi:10.1007/s11671-010-9683-1.
44. Hoppe JB, Coradini K, Frozza RL, Oliveira CM, Meneghetti AB, Bernardi A, Pires ES, Beck RCR, Salbego CG. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol Learn Mem 2013, 106:134-144. doi:10.1016/j.nlm.2013.08.001.
45. Zanotto-Filho A, Coradini K, Braganhol E, Schröder R, de Oliveira CM, Simões-Pires A, Moreira JCF. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm 2013, 83:156-167. doi:10.1016/j.ejpb.2012.10.019.
46. Haas SE, Bettoni CC, de Oliveira LK, Guterres SS, Dalla Costa T. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vitro. Int J Antimicrob Agents 2009, 34:156-161. doi:10.1016/j.ijantimicag.2009.02.024.
47. ®). Int J Pharm 2007, 334:166-172. doi:10.1016/j.ijpharm.2006.10.017.
48. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004, 99:53-62. doi:10.1016/j.jconrel.2004.06.015.
49. Bender EA, Cavalcante MF, Adorne MD, Colomé LM, Guterres SS, Abdalla DS, Pohlmann AR. New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL (-)-functionalized nanocapsules. Pharm Res 2014, 31:2975-2987. doi:10.1007/s11095-014-1392-5.
50. Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 2007, 117:163-170. doi:10.1016/j.jconrel.2006.10.023.
51. Brum TL, Fiel LA, Contri RV, Guterres SS, Pohlmann AR. Polymeric nanocapsules and lipid-core nanocapsules have diverse skin penetration. J Nanosci Nanotechnol 2014, 14:1-8. doi:10.1166/jnn.2014.9185.
52. Bender EA, Adorne MD, Colomé LM, Abdalla DS, Guterres SS, Pohlmann AR. Hemocompatibility of poly (ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm 2012, 426:271-279. doi:10.1016/j.ijpharm.2012.01.051.
53. Almouazen E, Bourgeois S, Jordheim LP, Fessi H, Briançon S. Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation. Pharm Res 2013, 30:1137-1146. doi:10.1007/s11095-012-0949-4.
54. Park MJ, Balakrishnan P, Yang SG. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm 2013, 441:757-764. doi:10.1016/j.ijpharm.2012.10.018.
55. Teixeira Z, Dreiss CA, Lawrence MJ, Heenan RK, Machado D, Justo GZ, Guterres SS, Durán N. Retinyl palmitate polymeric nanocapsules as carriers of bioactives. J Colloid Interface Sci 2012, 382:36-47. doi:10.1016/j.jcis.2012.05.042.
56. Mazzarino L, Dora CL, Bellettini IC, Minatti E, Cardoso SG, Lemos-Senna E. Curcumin-loaded polymeric and lipid nanocapsules: preparation, characterization and chemical stability evaluation. Lat Am J Pharm 2010, 29:933-940.
57. Teixeira Z, Zanchetta B, Melo BA, Oliveira LL, Santana MH, Paredes-Gamero EJ, Justo GZ, Nader HB, Guterres SS, Durán N. Retinyl palmitate flexible polymeric nanocapsules: characterization and permeation studies. Colloids Surf B Biointerfaces 2010, 81:374-380. doi:10.1016/j.colsurfb.2010.06.016.
58. Paolino D, Cosco D, Celano M, Moretti S, Puxeddu E, Russo D, Fresta M. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. Nanomedicine 2013, 8:193-201. doi:10.2217/NNM.12.101.
59. Bazylińska U, Lewińska A, Lamch Ł, Wilk KA. Polymeric nanocapsules and nanospheres for encapsulation and long sustained release of hydrophobic cyanine-type photosensitizer. Colloids Surf A Physicochem Eng Asp 2014, 442:42-49. doi:10.1016/j.colsurfa.2013.02.023.
60. Almouazen E, Bourgeois S, Boussaïd A, Valot P, Malleval C, Fessi H, Nataf S, Briançon S. Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages. Int J Pharm 2012, 430:207-215. doi:10.1016/j.ijpharm.2012.03.025.
61. De Paula CS, Tedesco AC, Primo FL, Vilela JMC, Andrade MS, Mosqueira VCF. Chloroaluminium phthalocyanine polymeric nanoparticles as photosensitisers: Photophysical and physicochemical characterisation, release and phototoxicity in vitro. Eur J Pharm Sci 2013, 49:371-381. doi:10.1016/j.ejps.2013.03.011.
62. Fontana MC, Coradini K, Pohlmann AR, Guterres SS, Beck RCR. Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability. J Nanosci Nanotechnol 2010, 10:3091-3099. doi:10.1166/jnn.2010.1920.
63. Paiva AM, Pinto RA, Teixeira M, Barbosa CM, Lima RT, Vasconcelos MH, Sousa E, Pinto M. Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interaction. Int J Pharm 2013, 454:394-402. doi:10.1016/j.ijpharm.2013.07.017.
64. Napimoga MH, da Silva CA, Carregaro V, Farnesi-de-Assunção TS, Duarte PM, de Melo NF, Fraceto LF. Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. J Immunol 2012, 189:1043-1052. doi:10.4049/jimmunol.1200730.
65. Stecanella LA, Taveira SF, Marreto RN, Valadares MC, Vieira MDS, Kato MJ, Lima EM. Development and characterization of PLGA nanocapsules of grandisin isolated from Virola surinamensis: in vitro release and cytotoxicity studies. Rev Bras Farmacogn 2013, 23:153-159. doi:10.1590/S0102-695X2012005000128.
66. de Melo NFS, Ferreira N, De Araujo DR, Grillo R, Moraes CM, De Matos AP, Fraceto LF. Benzocaine-loaded polymeric nanocapsules: study of the anesthetic activities. J Pharm Sci 2012, 101:1157-1165. doi:10.1002/jps.22829.
67. El-Gogary RI, Rubio N, Wang JTW, Al-Jamal WT, Bourgognon M, Kafa H, Naeem M, Klippstein R, Abbate V, Leroux F, et al. Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo. ACS Nano 2014, 8:1384-1401. doi:10.1021/nn405155b.
68. de Melo NFS, Grillo R, Guilherme VA, de Araujo DR, de Paula E, Rosa AH, Fraceto LF. Poly (lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm Res 2011, 28:1984-1994. doi:10.1007/s11095-011-0425-6.
69. Pietkiewicz J, Zielińska K, Saczko J, Kulbacka J, Majkowski M, Wilk KA. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur J Pharm Sci 2010, 39:322-335. doi:10.1016/j.ejps.2009.12.012.
70. Taheri S, Baier G, Majewski P, Barton M, Förch R, Landfester K, Vasilev K. Synthesis and antibacterial properties of a hybrid of silver-potato starch nanocapsules by miniemulsion/polyaddition polymerization. J Mater Chem B 2014, 2:1838-1845. doi:10.1039/c3tb21690j.
71. Rodriguez-Emmenegger C, Jäger A, Jäger E, Stepanek P, Alles A, Guterres SS, Pohlmann AR, Brynda E. Polymeric nanocapsules ultra stable in complex biological media. Colloids Surf B Biointerfaces 2011, 83:376-381. doi:10.1016/j.colsurfb.2010.12.013.
72. Paese K, Jäger A, Poletto FS, Pinto EF, Rossi-Bergmann B, Pohlmann AR, Guterres SS. Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol 2009, 5:240-246. doi:10.1166/jbn.2009.1028.
73. Poletto FS, Jäger E, Cruz L, Pohlmann AR, Guterres SS. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater Sci Eng C 2008, 28:472-478. doi:10.1016/j.msec.2007.04.015.
74. Jäger E, Venturini CG, Poletto FS, Colomé LM, Pohlmann JP, Bernardi A, Battastini AMO, Guterres SS, Pohlmann AR. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol 2009, 5:130-140. doi:10.1166/jbn.2009.1004.
75. Jäger A, Stefani V, Guterres SS, Pohlmann AR. Physico-chemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes. Int J Pharm 2007, 338:297-305. doi:10.1016/j.ijpharm.2007.01.051.
76. Venturini CG, Jäger E, Oliveira CP, Bernardi A, Battastini AM, Guterres SS, Pohlmann AR. Formulation of lipid core nanocapsules. Colloids Surf A Physicochem Eng Asp 2011, 375:200-208. doi:10.1016/j.colsurfa.2010.12.011.
77. Schaffazick SR, Siqueira IR, Badejo AS, Jornada DS, Pohlmann AR, Netto CA, Guterres SS. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 2008, 69:64-71. doi:10.1016/j.ejpb.2007.11.010.
78. St-Onge MP, Jones PJ. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr 2002, 132:329-332.
79. Safety of Manufactured Nanomaterials Guidelines' from the Organization for Economic Cooperation and Development (OECD). Avaliable at: http://www.oecd.org/science/nanosafety/publicationsintheseriesonthesafetyofmanufacturednanomaterials.htm. (Accessed December 4, 2014).